132 related articles for article (PubMed ID: 6813479)
1. Interim results of a multicenter open study with auranofin in Japan.
Homma M; Abe T; Akizuki M; Shiokawa Y; Shichikawa K; Kageyama T; Yoshizawa H; Azuma T; Mizushima Y; Okazaki T; Sugawara S
J Rheumatol Suppl; 1982; 8():160-8. PubMed ID: 6813479
[TBL] [Abstract][Full Text] [Related]
2. Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.
Bandilla K; Gross D; Gross W; Herrlinger JD; Kriegel W; Müller W; Siegmeth W; Tausch G; Thumb N; Wagenhäuser FJ
J Rheumatol Suppl; 1982; 8():154-9. PubMed ID: 6813478
[TBL] [Abstract][Full Text] [Related]
3. [Multicenter double-blind comparison of auranofin and Tauredon].
Kaik B; Bröll H
Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
[TBL] [Abstract][Full Text] [Related]
4. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
Siegmeth W
Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053
[TBL] [Abstract][Full Text] [Related]
5. Auranofin in rheumatoid arthritis.
Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
[No Abstract] [Full Text] [Related]
6. An open comparative study of auranofin vs. gold sodium thiomalate.
Smith PR; Brown GM; Meyers OL
J Rheumatol Suppl; 1982; 8():190-6. PubMed ID: 6813484
[TBL] [Abstract][Full Text] [Related]
7. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
[TBL] [Abstract][Full Text] [Related]
8. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
[TBL] [Abstract][Full Text] [Related]
10. Analysis of auranofin as a rheumatoid remitting agent.
Weisman MH; Hannifin DM; Guerra J; Resnik C; Resnick D
J Rheumatol Suppl; 1982; 8():132-6. PubMed ID: 6813474
[TBL] [Abstract][Full Text] [Related]
11. Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo.
Gofton JP; O'Brien WM; Hurley JN; Scheffler BJ
J Rheumatol; 1984 Dec; 11(6):768-71. PubMed ID: 6440982
[TBL] [Abstract][Full Text] [Related]
12. An European open multicentre trial with auranofin in rheumatoid arthritis.
Raeman F; Hanssens F; Delattre M
Clin Rheumatol; 1984 Mar; 3 Suppl 1():33-8. PubMed ID: 6432411
[TBL] [Abstract][Full Text] [Related]
13. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
14. Auranofin therapy in rheumatoid arthritis.
Bernhard GC
J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
[TBL] [Abstract][Full Text] [Related]
15. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
Bernhard GC
J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
[TBL] [Abstract][Full Text] [Related]
16. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
[TBL] [Abstract][Full Text] [Related]
17. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
[TBL] [Abstract][Full Text] [Related]
18. Auranofin versus placebo in the treatment of rheumatoid arthritis.
Wenger ME; Alexander S; Bland JH; Blechman WJ
Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
[TBL] [Abstract][Full Text] [Related]
19. An analysis of worldwide safety experience with auranofin.
Heuer MA; Pietrusko RG; Morris RW; Scheffler BJ
J Rheumatol; 1985 Aug; 12(4):695-9. PubMed ID: 3932651
[TBL] [Abstract][Full Text] [Related]
20. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
